LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NU7441 | 1.11 | uM | LJP5 | 3 | C09 | 72 | hr | 1476 | 2608 | 3694 | 0.7060 | 0.5102 |
| SK-BR-3 | Dactolisib | 1.11 | uM | LJP5 | 1 | M15 | 72 | hr | 1476 | 1694 | 3694 | 0.4586 | 0.0980 |
| SK-BR-3 | Dactolisib | 1.11 | uM | LJP5 | 2 | M15 | 72 | hr | 1476 | 1514 | 3694 | 0.4099 | 0.0168 |
| SK-BR-3 | Dactolisib | 1.11 | uM | LJP5 | 3 | M15 | 72 | hr | 1476 | 1607 | 3694 | 0.4350 | 0.0588 |
| SK-BR-3 | NVP-TAE684 | 1.11 | uM | LJP6 | 1 | K15 | 72 | hr | 1476 | 2356 | 3694 | 0.6378 | 0.3966 |
| SK-BR-3 | NVP-TAE684 | 1.11 | uM | LJP6 | 2 | K15 | 72 | hr | 1476 | 2777 | 3694 | 0.7518 | 0.5864 |
| SK-BR-3 | NVP-TAE684 | 1.11 | uM | LJP6 | 3 | K15 | 72 | hr | 1476 | 2458 | 3694 | 0.6654 | 0.4426 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 1 | E15 | 72 | hr | 1476 | 2491 | 3694 | 0.6743 | 0.4574 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 2 | E15 | 72 | hr | 1476 | 2673 | 3694 | 0.7236 | 0.5395 |
| SK-BR-3 | Palbociclib | 1.11 | uM | LJP6 | 3 | E15 | 72 | hr | 1476 | 2986 | 3694 | 0.8083 | 0.6807 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP5 | 1 | C03 | 72 | hr | 1476 | 3224 | 3694 | 0.8728 | 0.7880 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP5 | 2 | C03 | 72 | hr | 1476 | 3167 | 3694 | 0.8573 | 0.7623 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP5 | 3 | C03 | 72 | hr | 1476 | 2995 | 3694 | 0.8108 | 0.6847 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP6 | 1 | E03 | 72 | hr | 1476 | 2601 | 3694 | 0.7041 | 0.5070 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP6 | 2 | E03 | 72 | hr | 1476 | 3141 | 3694 | 0.8503 | 0.7506 |
| SK-BR-3 | PD0325901 | 1.11 | uM | LJP6 | 3 | E03 | 72 | hr | 1476 | 3370 | 3694 | 0.9123 | 0.8539 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 1476 | 4124 | 3694 | 1.1164 | 1.1939 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 1476 | 4406 | 3694 | 1.1927 | 1.3211 |
| SK-BR-3 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 1476 | 4278 | 3694 | 1.1581 | 1.2634 |
| SK-BR-3 | PD184352 | 1.11 | uM | LJP5 | 1 | L09 | 72 | hr | 1476 | 3886 | 3694 | 1.0520 | 1.0866 |
| SK-BR-3 | PD184352 | 1.11 | uM | LJP5 | 2 | L09 | 72 | hr | 1476 | 3653 | 3694 | 0.9889 | 0.9815 |
| SK-BR-3 | PD184352 | 1.11 | uM | LJP5 | 3 | L09 | 72 | hr | 1476 | 3933 | 3694 | 1.0647 | 1.1078 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 1 | I15 | 72 | hr | 1476 | 1422 | 3694 | 0.3849 | -0.0247 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 2 | I15 | 72 | hr | 1476 | 1625 | 3694 | 0.4399 | 0.0669 |
| SK-BR-3 | Pelitinib | 1.11 | uM | LJP5 | 3 | I15 | 72 | hr | 1476 | 1455 | 3694 | 0.3939 | -0.0098 |